Merck KGaA (OTCMKTS:MKGAF) Stock Price Up 10.1% – Here’s Why

Merck KGaA (OTCMKTS:MKGAF) rose 10.1% on Thursday . The company traded as high as $164.24 and last traded at $164.24. Approximately 425 shares were traded during mid-day trading, a decline of 35% from the average daily volume of 658 shares. The stock had previously closed at $149.1850.

Merck KGaA Stock Performance

The company has a market capitalization of $21.17 billion, a PE ratio of 25.00 and a beta of 0.96. The business’s fifty day moving average is $138.62 and its two-hundred day moving average is $141.62. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.

About Merck KGaA

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.